Table 1.
Demographic | With Pruritus within 3 Months of Drug (n = 9802) |
Without Pruritus After Receiving Drug (n = 1,085,404) |
p-Value * | p-Value ** |
---|---|---|---|---|
Gender, (%) | ||||
Male | 30.6 | 42.4 | <0.001 | <0.001 |
Female | 69.4 | 57.6 | <0.001 | |
Age, (%) | ||||
18–29 | 8.9 | 10.9 | <0.001 | <0.001 |
30–39 | 11.8 | 13.8 | <0.001 | |
40–49 | 12.6 | 13.5 | 0.009 | |
50–59 | 19.1 | 17.6 | <0.001 | |
60–69 | 20.4 | 18.8 | <0.001 | |
70–79 | 16.3 | 14.8 | <0.001 | |
80–89 | 8.4 | 7.6 | 0.003 | |
90–99 | 2.4 | 2.8 | 0.017 | |
100+ | 0.1 | 0.2 | 0.027 | |
Race (%) | ||||
White/Caucasian | 48.1 | 62.8 | <0.001 | <0.001 |
Black/African American | 38.9 | 23.1 | <0.001 | |
Asian | 4.2 | 4.3 | 0.627 | |
American Indian/Alaska Native | 0.4 | 0.3 | 0.072 | |
Native Hawaiian/Pacific Islander | 0.2 | 0.1 | 0.002 | |
Other | 7.7 | 7.4 | 0.259 | |
Unknown | 0.5 | 1.8 | <0.001 | |
Declined to answer | 0.2 | 0.3 | 0.071 |
* Calculated by the chi-squared test for overall difference in proportions. ** Pairwise comparisons calculated using the student’s t-test with Bonferroni correction for significance (p < 0.003).